NCT03040687View on ClinicalTrials.gov

Efficacy of B7A BSIgG Against E. Coli Strain B7A Challenge

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

April 30, 2017

Study Completion Date

August 31, 2017

Conditions
Healthy Volunteer
Interventions
BIOLOGICAL

Anti CS6 BSIgG product (Lot PD1601105CS)

BIOLOGICAL

Anti B7A BSIgG product (Lot PD1601132ET)

BIOLOGICAL

Bovine Immunoglobin Negative Control (Lot PD161071NC)

BIOLOGICAL

B7A- CS6-expressing ETEC challenge strain

Trial Locations (1)

21205

Johns Hopkins Center for Immunization Research, Baltimore

Sponsors
All Listed Sponsors
collaborator

Naval Medical Research Center

FED

collaborator

United States Department of Defense

FED

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT03040687 - Efficacy of B7A BSIgG Against E. Coli Strain B7A Challenge | Biotech Hunter | Biotech Hunter